Jun. 30 at 7:11 AM
$CRVO I still think management made a major IR mistake. Not because of the offering itself, that was logical and expected in biotec, but because of the timing. They turned a strong momentum breakout into panic selling.
The fundamentals didn’t suddenly disappear. The pipeline is the same. Now we just need a catalyst… or volume. Until then, it’s mostly dead money. But with such a small float, sentiment can flip very fast.
